CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Cash Flows [Abstract]
Total cash, cash equivalents, and restricted cash	$ 20,737	$ 25,935	$ 17,741
Cash flows from operating activities
Net income/(loss)	17,910	(1,276)	84
Depreciation and tooling amortization	7,318	8,751	9,689
Other amortization	(1,358)	(1,294)	(1,199)
Held-for-sale impairment charges	0	23	804
Brazil manufacturing exit non-cash charges (excluding accelerated depreciation of $145 and $322) (Note 21)	48	1,159	0
(Gains)/Losses on Extinguishment of Debt	1,702	1	55
Provision for/(Benefit from) credit and insurance losses	(298)	929	413
Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash	(4,865)	1,027	2,625
Equity investment dividends received in excess of (earnings)/losses	116	130	203
Foreign currency adjustments	532	(420)	(54)
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	(9,159)	(315)	(139)
Net (gain)/loss on changes in investments in affiliates	(368)	(3,446)	(29)
Stock compensation (Note 6)	305	199	228
Deferred Income Taxes and Tax Credits	(563)	(269)	(1,370)
Increase (Decrease) in Finance Receivables	7,656	12,104	1,554
Decrease/(Increase) in accounts receivable and other assets	(1,141)	(63)	(816)
Decrease/(Increase) in inventory	(1,778)	148	206
Increase/(Decrease) in accounts payable and accrued and other liabilities	(36)	6,809	5,260
Other	(234)	72	125
Net cash provided by/(used in) operating activities	15,787	24,269	17,639
Cash flows from investing activities
Capital spending	(6,227)	(5,742)	(7,632)
Acquisitions of finance receivables and operating leases	(48,379)	(55,901)	(55,576)
Collections of finance receivables and operating leases	52,094	48,746	50,182
Proceeds from Divestiture of Interest in Consolidated Subsidiaries	145	1,340	0
Payments to Acquire Marketable Securities	(27,491)	(39,624)	(17,472)
Sales and maturities of marketable securities and other investments	33,229	32,395	16,929
Settlements of derivatives	(272)	(323)	(114)
Other	(354)	494	(38)
Net Cash Provided by (Used in) Investing Activities	2,745	(18,615)	(13,721)
Cash flows from financing activities
Cash payments for dividends and dividend equivalents	(403)	(596)	(2,389)
Purchases of common stock	0	0	(237)
Net changes in short-term debt	3,273	(2,291)	(1,384)
Proceeds from issuance of long-term debt	27,901	65,900	47,604
Payments of long-term debt	(54,164)	(60,514)	(46,497)
Other	(105)	(184)	(226)
Net Cash Provided by (Used in) Financing Activities	(23,498)	2,315	(3,129)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(232)	225	45
Cash, cash equivalents, and restricted cash at beginning of period (Note 9)	25,935	17,741	16,907
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(5,198)	8,194	834
Cash, cash equivalents, and restricted cash at end of period (Note 9)	20,737	25,935	$ 17,741
Cash and cash equivalents
Cash, cash equivalents, and restricted cash at end of period (Note 9)	$ 20,540	$ 25,243